发明名称 THYROSINKINASE INHIBITORS
摘要 FIELD: chemistry. ^ SUBSTANCE: in compound of formula I , R1 is hydrogen; R2 is phenyl substituted by trifluoromethyl and optionally by other substitute selected out of a group including lower hydroxyl alkyl, lower alkylamino, lower hydroxyl alkylamino, dilower alkylamino, 1H-imidazolyl, lower alkyl-1H-imidazolyl, carbamoyl, lower alkylcarbamoyl, pyrrolidino, piperazino, lower alkylpiperazino, morpholino, lower alkoxy, trilfuoro-lower alkoxy, phenyl, pyridyl and halogenyl; R4 is methyl; where 'lower' prefix denotes radical with up to 7 carbon atoms. Also invention concerns pharmaceutical composition and method of treatment, as well as application of the claimed compounds in obtaining pharmaceutical composition. ^ EFFECT: improved proteinkinase inhibition properties. ^ 9 cl, 98 ex
申请公布号 RU2348627(C2) 申请公布日期 2009.03.10
申请号 RU20050102917 申请日期 2003.07.04
申请人 NOVARTIS AG 发明人 BRAJTENSHTAJN VERNER;FJURE PASKAL';DZHEJKOB SANDRA;MANLI POL UILL'JAM
分类号 C07D401/04;C07D401/14;A61K31/506;A61K31/5377;A61K31/55;A61P35/00;A61P35/02;A61P43/00;C07D405/14;C07D413/14;C07D417/14 主分类号 C07D401/04
代理机构 代理人
主权项
地址